Myrodia Therapeutics

Kaldur therapeutics

This biotech company develops medications and biomarkers to manipulate the hypothermia response for patients suffering from cardiac arrest or neonatal asphyxia.

Clotprotect Therapeutics

This company develops small molecule anti-fibrinolytic drugs for patients suffering from acute haemorrhage and severe bleeding.

ClotProtect

This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.

Enodia

This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

Vandria

This biopharmaceutical company develops small molecule mitophagy inducers to treat patients with age-related and chronic diseases, specifically targeting neurodegenerative and muscle disorders.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Pano Therapeautics

This biotechnology company develops small molecule drugs targeting mitochondrial ion channels to treat neurodevelopmental disorders and complex diseases of aging.